USANA Health Sciences, Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 79,294 shares of the stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $57.61, for a total value of $4,568,127.34. Following the sale, the insider now owns 12,272,013 shares in the company, valued at approximately $706,990,668.93. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Global Ltd Gull also recently made the following trade(s):

  • On Tuesday, September 5th, Global Ltd Gull sold 40,000 shares of USANA Health Sciences stock. The shares were sold at an average price of $58.41, for a total value of $2,336,400.00.
  • On Wednesday, August 2nd, Global Ltd Gull sold 14,533 shares of USANA Health Sciences stock. The shares were sold at an average price of $56.71, for a total value of $824,166.43.
  • On Tuesday, August 1st, Global Ltd Gull sold 25,467 shares of USANA Health Sciences stock. The shares were sold at an average price of $56.52, for a total value of $1,439,394.84.

Shares of USANA Health Sciences, Inc. (USNA) opened at 57.00 on Friday. The stock has a market cap of $1.39 billion, a price-to-earnings ratio of 14.81 and a beta of 1.10. USANA Health Sciences, Inc. has a 1-year low of $52.55 and a 1-year high of $75.00. The firm has a 50-day moving average price of $57.61 and a 200-day moving average price of $60.16.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, July 25th. The company reported $0.98 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.06 by ($0.08). The company had revenue of $257.10 million for the quarter, compared to analyst estimates of $273.61 million. USANA Health Sciences had a return on equity of 28.93% and a net margin of 9.47%. The business’s quarterly revenue was down .5% on a year-over-year basis. During the same period last year, the firm posted $2.07 EPS. Equities analysts forecast that USANA Health Sciences, Inc. will post $3.79 EPS for the current year.

USANA Health Sciences announced that its board has approved a share buyback plan on Tuesday, July 25th that allows the company to repurchase $64.60 million in outstanding shares. This repurchase authorization allows the company to buy up to 46% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: “Global Ltd Gull Sells 79,294 Shares of USANA Health Sciences, Inc. (USNA) Stock” was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://www.dailypolitical.com/2017/09/16/global-ltd-gull-sells-79294-shares-of-usana-health-sciences-inc-usna-stock.html.

A number of large investors have recently bought and sold shares of the business. USA Financial Portformulas Corp purchased a new stake in USANA Health Sciences in the second quarter valued at $691,000. Phocas Financial Corp. raised its position in USANA Health Sciences by 4.7% in the second quarter. Phocas Financial Corp. now owns 125,090 shares of the company’s stock valued at $8,018,000 after purchasing an additional 5,575 shares during the period. California State Teachers Retirement System raised its position in USANA Health Sciences by 0.5% in the second quarter. California State Teachers Retirement System now owns 20,582 shares of the company’s stock valued at $1,319,000 after purchasing an additional 100 shares during the period. The Manufacturers Life Insurance Company raised its position in USANA Health Sciences by 7.2% in the second quarter. The Manufacturers Life Insurance Company now owns 9,137 shares of the company’s stock valued at $586,000 after purchasing an additional 616 shares during the period. Finally, Arrowstreet Capital Limited Partnership raised its position in USANA Health Sciences by 711.5% in the second quarter. Arrowstreet Capital Limited Partnership now owns 91,409 shares of the company’s stock valued at $5,859,000 after purchasing an additional 80,145 shares during the period. Institutional investors own 44.90% of the company’s stock.

Several research firms recently weighed in on USNA. BidaskClub upgraded USANA Health Sciences from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 22nd. Pivotal Research decreased their price target on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating on the stock in a report on Wednesday, July 26th.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.